Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 8, 2021
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
Pedro Rocha, Ruth Salazar, Jiexin Zhang, et al.
Stroke
|
July 25, 2024
Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke
Ricardo Varela, Fernando Gonzalez-Ortiz, Alexandre Dias, et al.
Cell Reports. Medicine
|
June 21, 2025
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer
Raúl Del Rey-Vergara, Miguel Alejandro Galindo-Campos, Pedro Rocha, et al.
British Journal of Cancer
|
April 20, 2022
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Bingnan Zhang, C Allison Stewart, Qi Wang, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Marta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Cancer Cell
|
January 26, 2024
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
Simon Heeke, Carl M Gay, Marcos R Estecio, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Cancer Immunology, Immunotherapy : CII
|
January 8, 2021
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
Pedro Rocha, Ruth Salazar, Jiexin Zhang, et al.
Stroke
|
July 25, 2024
Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke
Ricardo Varela, Fernando Gonzalez-Ortiz, Alexandre Dias, et al.
Cell Reports. Medicine
|
June 21, 2025
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer
Raúl Del Rey-Vergara, Miguel Alejandro Galindo-Campos, Pedro Rocha, et al.
British Journal of Cancer
|
April 20, 2022
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Bingnan Zhang, C Allison Stewart, Qi Wang, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Marta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Cancer Cell
|
January 26, 2024
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
Simon Heeke, Carl M Gay, Marcos R Estecio, et al.
Page
of 14